Breakthrough blood test developed for early detection of sarcoidosis

A research project led by Lobelia Samavati, M.D., professor of internal medicine and molecular medicine and genetics at the Wayne State University School of Medicine, and supported by the National Institutes of Health (NIH), has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas in the lungs and other organs.

Steve Jobs’ son to lead Emerson Collective’s oncology-focused VC firm Yosemite

Emerson Collective, the VC firm from billionaire Laurene Powell Jobs, has formed an oncology-focused investment fund that will be led by Reed Jobs, her son

August 3, 2023

Illumina began hunt for CEO candidates in midst of activist fight, eventually picking little-known diagnostics exec

Illumina’s board began looking for potential CEO replacements approximately two months before the resignation of then-leader Francis deSouza, during an intense proxy campaign targeting the

September 6, 2023

Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023 | Psychedelic Invest

Numinus Wellness Inc. (TSX: NUMI / OTCQX: NUMIF) – a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest,

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.